Navigation Links
Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension

mately four hours and in this study showed similar efficacy in a once-daily dose compared to ibuprofen given three times a day.

The clinical trial database for lumiracoxib comprises approximately 40,000 patients, making it one of the largest bodies of evidence for any drug in its class. This includes the results of TARGET (Therapeutic Arthritis Research and Gastrointestinal Trial) involving more than 18,000 patients. Results of this trial showed lumiracoxib also significantly reduced the incidence of upper gastrointestinal complications by 79% in patients not taking aspirin compared to ibuprofen and naproxen.

In TARGET, serious adverse events were reported in 6% of patients receiving lumiracoxib, the same rate seen in patients receiving ibuprofen or naproxen. Adverse events requiring study discontinuation occurred in 16% of lumiracoxib patients and 18% of NSAID patients.

The most frequently occurring gastrointestinal (GI) events were dyspepsia (25% of lumiracoxib patients compared with 26% of NSAID patients) and upper abdominal pain (10% vs. 13%). All other GI events occurred in less than 10% of patients in both groups. In an analysis of cardiovascular outcomes in TARGET, the incidence of events -- defined as non-fatal and silent myocardial infarction, stroke, or cardiovascular death -- was low and comparable in both groups. At one year, there were 59 events in the group of patients taking lumiracoxib (0.65%) and 50 events in the group taking NSAIDs (0.55%, p=0.5074).

Disclaimer

The foregoing press release contains forward-looking statements such as "can," "may," or similar expressions, or by express or implied discussions regarding potential future regulatory filings or approvals or potential future sales of lumiracoxib. Such forward-looking statements reflect the current views of Novartis regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results with lumiracoxib to
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:7/10/2014)... 10, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... has completed the sale to Galderma of all rights ... held by Valeant for $1.4 billion in cash, pursuant ... recently completed its acquisition of Galderma. ... products to a company that is firmly committed to ...
(Date:7/10/2014)... , July 10, 2014  Decision Resources Group ... infectious disease (ID) specialists are willing to prescribe ... (oritavancin) for use as OPAT, approximately two-thirds of ... agents to their hospital inpatients. However, our findings ... patients are initiated on OPAT following hospital discharge, ...
(Date:7/10/2014)... , July 10, 2014 CVS Caremark Corporation (NYSE: ... directors has approved a quarterly dividend of $0.275 (27.5 cents) ... payable on August 1, 2014, to holders of record on ... CVS Caremark is dedicated to helping people on their ... in the United States . Through the ...
Breaking Medicine Technology:Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3
... Employment Awareness Month marks the 20th anniversary ... the cutting-edge voice of disability culture in America. ... and edited by staff and freelancers with disabilities, encourages ... while simultaneously reflecting the vibrant world of disability-related arts, ...
... PHILADELPHIA, Oct. 21 Sanovia, a leading provider ... it has been selected by HealthSpring, Inc. to ... HealthSpring, one of the largest Medicare Advantage coordinated ... reinforces Sanovia,s leadership in delivering pharmaceutical prior authorization ...
Cached Medicine Technology:Award-Winning Disability Lifestyle Magazine Celebrates 20 Years of Publication - And 20 Years of Employing People with Disabilities 2Sanovia Selected to Deliver PA-Logic(TM) Pharmaceutical Prior Authorization Platform to HealthSpring 2Sanovia Selected to Deliver PA-Logic(TM) Pharmaceutical Prior Authorization Platform to HealthSpring 3
(Date:7/13/2014)... (PRWEB) July 13, 2014 Hope Palliative & ... monthly grief support group at the Tamarack Senior Living Community ... held at 10:30 A.M. on the 3rd Wednesdays of every ... 2014 at the Tamarack Community located at 55 S. Greeley ... bereaved individuals and there is no cost for the group. ...
(Date:7/12/2014)... July 13, 2014 According to the ... (Land Systems, Airborne Systems, and Naval Systems) - Global ... MarketsandMarkets, Security and Surveillance Radar market are estimated to ... register a CAGR of 5.97% to reach $8.61 billion ... tables with 47 figures spread through 161 pages and ...
(Date:7/12/2014)... Fresh off their respective performances in the 2014 World ... 5th at Sun Life Stadium in an international friendly. The ... brightest stars in the world of football in Colombian and ... to some of the best talent in the world in ... best team in the world according to the Fédération Internationale ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 ... research report, ‘cognitive assessment and training’ is ... monitor, assess, train, or enhance cognitive functions. ... such as in dementia screening, clinical trials, ... classroom learning, self assessment, brain training, and ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 Casinos ... years, despite rising competition from international and online casinos. ... 2.9% over the five years through 2014-15. Greater per ... demanding more gaming services. Rises in discretionary income levels ... more money on non-essential items such as casino gambling ...
Breaking Medicine News(10 mins):Health News:Hope Hospice Announces Grief Support Group at the Tamarack Senior Living Community 2Health News:Security and Surveillance Radar Market Estimated to Reach $8.61 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Security and Surveillance Radar Market Estimated to Reach $8.61 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Security and Surveillance Radar Market Estimated to Reach $8.61 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Brazil Vs. Colombia Tickets Sun Life Stadium: Ticket Down Slashes Ticket Prices for Friendly Match Between Colombia and Brazil 2Health News:Brazil Vs. Colombia Tickets Sun Life Stadium: Ticket Down Slashes Ticket Prices for Friendly Match Between Colombia and Brazil 3Health News:Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at LifeScienceIndustryResearch.com 2Health News:Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at LifeScienceIndustryResearch.com 3Health News:Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at LifeScienceIndustryResearch.com 4Health News:Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at LifeScienceIndustryResearch.com 5Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 4
... All," Interaction Associates Senior Consultant Jay Gordon Cone provides a model ... teams are high-performing - and decide what to do if they,re ... ... of the work of business today takes place in team environments. ...
... Journal of Hematology by scientists from the Fudan-Cinpathogen ... Shanghai, in collaboration with the University of ... subtypes of chronic lymphoid neoplasms are not as ... Diagnosis and classification were performed by a single ...
... with current US treatment guidelines to start ... 80% of patients may need multiple medications to help them reach ... blood pressure goals, - Single-pill ... could help patients reach treatment goals faster, - Diovan HCT and ...
... or at the neighborhood pool, diving is one of the ... of people do it* and every four years during the ... you that researchers are just now delving into the dangers ... competing at the highest levels of diving takes persistence. Day ...
... children and a highly touted botanical extract (COLD-fX) show ... Canadian cold and flu remedy. The results appear in ... the official journal of the American Academy of Pediatrics. ... was conducted in collaboration with the University of Alberta ...
... Today, the University,HealthSystem Consortium (UHC) announced that ... medical center (AMC) in Jackson, has,been added to ... chain,participants., "Moving to UHC for our group ... strategic partner that is committed to meeting our,unique ...
Cached Medicine News:Health News:New White Paper by Performance Improvement Innovator Interaction Associates Helps Business Leaders Assess Team Effectiveness 2Health News:Fudan-Cinpathogen Study Shows Chronic Lymphoid Neoplasms are More Common in Shanghai Than Thought 2Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 2Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 3Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 4Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 5Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 6Health News:Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure 7Health News:First national study of diving-related injuries 2Health News:First national study of diving-related injuries 3Health News:Canadian study of colds and kids: Positive safety results for ginseng extract 2Health News:University of Mississippi Health Care Selects UHC for Group Purchasing Services 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: